145 related articles for article (PubMed ID: 16485145)
41. Esophageal cancer: preoperative or definitive chemoradiation.
Urba S
Ann Oncol; 2004; 15 Suppl 4():iv93-6. PubMed ID: 15477343
[No Abstract] [Full Text] [Related]
42. [Surgical treatment of esophageal neoplasms with preoperative extensive radiation and administration of antineoplastic drugs].
Watanabe H; Karasawa K; Okada K; Akane Y; Miura S
Nihon Kyobu Geka Gakkai Zasshi; 1973 Mar; 21(3):279-80. PubMed ID: 4141365
[No Abstract] [Full Text] [Related]
43. [Morphological changes of esophageal cancer after preoperative radiation therapy].
Gosh TE; Pirogov AI; Gritsman IuIa; Papliian NP; Mamontov AS
Med Radiol (Mosk); 1974 Jul; 19(7):21-6. PubMed ID: 4410178
[No Abstract] [Full Text] [Related]
44. Chemoradiation in the management of esophageal cancer.
Kleinberg L; Forastiere AA
J Clin Oncol; 2007 Sep; 25(26):4110-7. PubMed ID: 17827461
[TBL] [Abstract][Full Text] [Related]
45. Chemoradiotherapy for localized esophageal cancer: regimen selection and molecular mechanisms of radiosensitization.
Kleinberg L; Gibson MK; Forastiere AA
Nat Clin Pract Oncol; 2007 May; 4(5):282-94. PubMed ID: 17464336
[TBL] [Abstract][Full Text] [Related]
46. Radiation therapy for esophageal cancer in Japan: results of the Patterns of Care Study 1999-2001.
Kenjo M; Uno T; Murakami Y; Nagata Y; Oguchi M; Saito S; Numasaki H; Teshima T; Mitsumori M
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):357-63. PubMed ID: 19735863
[TBL] [Abstract][Full Text] [Related]
47. Prospective comparison of surgery alone and chemoradiotherapy with selective surgery in resectable squamous cell carcinoma of the esophagus.
Ariga H; Nemoto K; Miyazaki S; Yoshioka T; Ogawa Y; Sakayauchi T; Jingu K; Miyata G; Onodera K; Ichikawa H; Kamei T; Kato S; Ishioka C; Satomi S; Yamada S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):348-56. PubMed ID: 19735862
[TBL] [Abstract][Full Text] [Related]
48. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
[TBL] [Abstract][Full Text] [Related]
49. Oesophageal cancer: a view over overviews.
Munro AJ
Lancet; 2004 Aug 14-20; 364(9434):566-8. PubMed ID: 15313344
[No Abstract] [Full Text] [Related]
50. [Preoperative irradiation of cancer--its theory and practice, with special reference to esophageal cancer].
Nakayama K; Yazawa C; Kobayashi S; Kinoshita S
Geka Chiryo; 1968 Mar; 18(3):327-35. PubMed ID: 5696068
[No Abstract] [Full Text] [Related]
51. [Neoadjuvant therapy in oesophageal cancer surgery].
Imdahl A
Zentralbl Chir; 2006 Apr; 131(2):105-9. PubMed ID: 16612775
[TBL] [Abstract][Full Text] [Related]
52. [An appropriate chemotherapy for esophageal cancer from a histological standpoint].
Hayashi K; Nakamura T; Narumiya K; Yamamoto M
Gan To Kagaku Ryoho; 2009 Feb; 36(2):182-6. PubMed ID: 19223733
[TBL] [Abstract][Full Text] [Related]
53. Multimodality therapy for the curative treatment of cancer of the esophagus and gastroesophageal junction.
Ku GY; Ilson DH
Expert Rev Anticancer Ther; 2008 Dec; 8(12):1953-64. PubMed ID: 19046115
[TBL] [Abstract][Full Text] [Related]
54. [Surgery and adjuvant therapy of esophageal cancer, with special reference to preoperative administration of BLM].
Koizumi H; Suda T; Suzuki M; Tomita Y; Kishima H
Nihon Kyobu Geka Gakkai Zasshi; 1978 Mar; 26(3):237-8. PubMed ID: 81247
[No Abstract] [Full Text] [Related]
55. Influence of induction chemotherapy and class of cytotoxics on pathologic response and survival after preoperative chemoradiation in patients with carcinoma of the esophagus.
Javeri H; Arora R; Correa AM; Hofstetter WL; Lee JH; Liao Z; McAleer MF; Maru D; Bhutani MS; Swisher SG; Izzo JG; Ajani JA
Cancer; 2008 Sep; 113(6):1302-8. PubMed ID: 18623381
[TBL] [Abstract][Full Text] [Related]
56. [Cancer of the esophagus].
Guarner V
Rev Gastroenterol Mex; 1983; 48(3):155-62. PubMed ID: 6658295
[No Abstract] [Full Text] [Related]
57. The value of preoperative radiotherapy in esophageal cancer: results of a study by the EORTC.
Gignoux M; Roussel A; Paillot B; Gillet M; Schlag P; Dalesio O; Buyse M; Duez N
Recent Results Cancer Res; 1988; 110():1-13. PubMed ID: 3043582
[No Abstract] [Full Text] [Related]
58. Setback for systemic therapy of esophageal cancer: right concept, disappointing result.
O'Sullivan GC; Shanahan F; Talwalkar J; Van Dam J
Gastroenterology; 1999 Oct; 117(4):1020-2. PubMed ID: 10500088
[No Abstract] [Full Text] [Related]
59. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
60. Esophageal cancer: current and emerging therapy modalities.
Ekman S; Dreilich M; Lennartsson J; Wallner B; Brattström D; Sundbom M; Bergqvist M
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1433-48. PubMed ID: 18759695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
